Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1997 1
2002 5
2003 2
2004 1
2005 4
2006 2
2008 1
2009 2
2010 1
2011 9
2012 6
2013 3
2014 5
2015 4
2016 5
2017 5
2018 6
2019 10
2020 11
2021 19
2022 13
2023 15
2024 5

Text availability

Article attribute

Article type

Publication date

Search Results

117 results

Results by year

Filters applied: . Clear all
Page 1
Early estimates of nirsevimab immunoprophylaxis effectiveness against hospital admission for respiratory syncytial virus lower respiratory tract infections in infants, Spain, October 2023 to January 2024.
López-Lacort M, Muñoz-Quiles C, Mira-Iglesias A, López-Labrador FX, Mengual-Chuliá B, Fernández-García C, Carballido-Fernández M, Pineda-Caplliure A, Mollar-Maseres J, Shalabi Benavent M, Sanz-Herrero F, Zornoza-Moreno M, Pérez-Martín JJ, Alfayate-Miguelez S, Pérez Crespo R, Bastida Sánchez E, Menasalvas-Ruiz AI, Téllez-González MC, Esquiva Soto S, Del Toro Saravia C, Sanz-Muñoz I, Eiros JM, Matías Del Pozo V, Toquero-Asensi M, Pastor-Villalba E, Lluch-Rodrigo JA, Díez-Domingo J, Orrico-Sánchez A. López-Lacort M, et al. Among authors: eiros jm. Euro Surveill. 2024 Feb;29(6):2400046. doi: 10.2807/1560-7917.ES.2024.29.6.2400046. Euro Surveill. 2024. PMID: 38333937 Free PMC article.
Synergistic impact of N-antigenemia profiled by a rapid antigen test and low anti-S1 antibodies on the risk of hospitalization in COVID-19.
de la Fuente A, Postigo T, Sanus Ferri F, Domínguez-Gil M, Álvarez-Manzanares J, Eiros JM, Carbajosa Rodríguez V, Sanchez Ramon S, Ortega A, Fadrique Millán LN, Vaquero-Roncero LM, Esteban-Velasco C, Navarro-Matías E, Barbé F, Bermejo-Martin JF, Lopez-Izquierdo R. de la Fuente A, et al. Among authors: eiros jm. Int J Infect Dis. 2024 Mar;140:132-135. doi: 10.1016/j.ijid.2024.01.018. Epub 2024 Feb 2. Int J Infect Dis. 2024. PMID: 38311026 Free article.
Human T-lymphotropic virus-1 infection among Latin American pregnant women living in Spain.
Encinas B, Benito R, Rojo S, Reina G, Montiel N, Aguilera A, Eiros JM, García-Costa J, Ortega D, Arco I, Hernánez-Batancor A, Soriano V, de Mendoza C; Spanish HTLV Network. Encinas B, et al. Among authors: eiros jm. IJID Reg. 2023 Nov 22;10:146-149. doi: 10.1016/j.ijregi.2023.11.010. eCollection 2024 Mar. IJID Reg. 2023. PMID: 38304758 Free PMC article.
HTLV-1-associated myelopathy in Spain.
de-Mendoza C, Pérez L, Rando A, Reina G, Aguilera A, Benito R, Eirós JM, Rodríguez-Avial I, Ortega D, Pozuelo MJ, Pena MJ, Soriano V; Spanish HTLV Network. de-Mendoza C, et al. Among authors: eiros jm. J Clin Virol. 2023 Dec;169:105619. doi: 10.1016/j.jcv.2023.105619. Epub 2023 Nov 21. J Clin Virol. 2023. PMID: 38000189
Group 1 and group 2 hemagglutinin stalk antibody response according to age.
Sánchez-de Prada L, Sanz-Muñoz I, Sun W, Palese P, Ortiz de Lejarazu R, Eiros JM, García-Sastre A, Aydillo T. Sánchez-de Prada L, et al. Among authors: eiros jm. Front Immunol. 2023 May 29;14:1194073. doi: 10.3389/fimmu.2023.1194073. eCollection 2023. Front Immunol. 2023. PMID: 37313413 Free PMC article.
117 results